药品名称OVCON-35
申请号018127产品号001
活性成分ETHINYL ESTRADIOL; NORETHINDRONE市场状态停止上市
剂型或给药途径TABLET;ORAL-21规格0.035MG;0.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构WARNER CHILCOTT INC
化学类型New dosage form审评分类Standard review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
018127034AP1997/11/14Control Supplement
018127033AP1998/08/10Labeling Revision
018127032AP1995/07/07Package Change
018127031AP1995/02/14Package Change
018127030AP1995/01/25Labeling Revision
018127029AP1993/03/12Control Supplement
018127028AP1993/03/12Labeling Revision
018127027AP1994/04/08Manufacturing Change or Addition
018127025AP1995/01/25Labeling Revision
018127024AP1992/07/21Labeling Revision
018127023AP1991/07/24Manufacturing Change or Addition
018127022AP1991/03/12Control Supplement
018127020AP1989/08/24Labeling Revision
018127019AP1986/03/18Control Supplement
018127015AP1984/10/01Package Change
018127014AP1984/12/03Labeling Revision
018127013AP1984/01/23Control Supplement
018127012AP1983/03/25Labeling Revision
018127011AP1983/02/08Control Supplement
018127010AP1982/11/05Control Supplement
018127008AP1981/04/14Labeling Revision
018127005AP1980/01/14Labeling Revision
018127004AP1979/08/29Package Change
018127003AP1979/06/04Labeling Revision
018127001AP1979/01/19Labeling Revision
018127000AP1978/07/05Approval